Your Global Leader in Stem Cell Market Research
IRVINE, CALIFORNIA, USA, August 10, 2021 — HealthBanks Biotech, Inc. (“HealthBanks” or the “Company”), a premium U.S. stem cell and immune cell bank headquartered in Irvine, CA, today announces the launch of its newest cord blood banking membership plans and prices. [Read more…]
DRESDEN, Germany, August. 11, 2021 /BioInformant/ — denovoMATRIX GmbH, a leading developer of technologies which enable high quality stem cell expansion, today announced the publication of patent application US2021/0145980, titled ‘non-covalently assembled matrix layer’. The patent is expected to provide broad protection for denovoMATRIX’ proprietary screenMATRIX and myMATRIX product lines in the Unites States. [Read more…]
NASHVILLE, TN, July 22, 2021 — EV Biologics (OTC PINK:YECO) announced that it has signed a Letter of Intent (LOI) with Lonza Cell & Gene Therapy for Process Development and Gap Analysis for biomanufacturing of a novel therapeutic composition, comprising extracellular vesicles (EVs) and particles, as well as other secreted factors derived from selected stem/progenitor cells, such as mesenchymal stromal cells (MSCs). [Read more…]
Miami, FL (July 21, 2021) — Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for its lead product, Zofin™, for the treatment of ‘Prolonged COVID-19 Symptoms’ (“Long Haulers”). [Read more…]
